0001209191-19-059280.txt : 20191205
0001209191-19-059280.hdr.sgml : 20191205
20191205160514
ACCESSION NUMBER: 0001209191-19-059280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191203
FILED AS OF DATE: 20191205
DATE AS OF CHANGE: 20191205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TOMSICEK MICHAEL JOHN
CENTRAL INDEX KEY: 0001570392
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 191270461
MAIL ADDRESS:
STREET 1: 28 OVERLOOK DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-03
0
0001674416
CRISPR Therapeutics AG
CRSP
0001570392
TOMSICEK MICHAEL JOHN
C/O CRISPR THERAPEUTICS, INC.
610 MAIN STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Financial Officer
Restricted Stock Units
2019-12-03
4
A
0
20000
0.00
A
Common Shares
20000
20000
D
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.
/s/ Michael Esposito, attorney-in-fact
2019-12-05